Observational studyProstate cancer and prostatic diseases2025

Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS).

Benjamin L Maughan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.